SKP2 induces tumorigenesis via Hippo signaling (Zhang et al., 2017) in HCC, and promotes tumor progression in breast cancer via PDCD4 ubiquitination (Li et al., 2019). This evidence concerns the gene SKP2 and neoplasm.